Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation
- 8 August 2012
- journal article
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 13 (8), 616-623
- https://doi.org/10.1631/jzus.b1201004
Abstract
Mesenchymal stem cell (MSC) transplantation is a promising therapy for ischemic heart diseases. However, poor cell survival after transplantation greatly limits the therapeutic efficacy of MSCs. The purpose of this study was to investigate the protective effect of angiopoietin-1 (Ang1) preconditioning on MSC survival and subsequent heart function improvement after transplantation. MSCs were cultured with or without 50 ng/ml Ang1 in complete medium for 24 h prior to experiments on cell survival and transplantation. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Hoechst staining were applied to evaluate MSC survival after serum deprivation in vitro, while cell survival in vivo was detected by terminal deoxynucleotidyl transferase biotin-dUPT nick end labeling (TUNEL) assay 24 and 72 h after transplantation. Heart function and infarct size were measured four weeks later by small animal echocardiography and Masson’s trichrome staining, respectively. Ang1 preconditioning induced Akt phosphorylation and increased expression of Bcl-2 and the ratio of Bcl-2/Bax. In comparison with non-preconditioned MSCs, Ang1-preconditioned cell survival was significantly increased while the apoptotic rate decreased in vitro. However, the PI3K/Akt pathway inhibitor, LY294002, abrogated the protective effect of Ang1 preconditioning. After transplantation, the Ang1-preconditioned-MSC group showed a lower death rate, smaller infarct size, and better heart functional recovery compared to the non-preconditioned-MSC group. Ang1 preconditioning enhances MSC survival, contributing to further improvement of heart function.Keywords
This publication has 24 references indexed in Scilit:
- Overexpression of Angiopoietin-1 Increases CD133+/c-kit+ Cells and Reduces Myocardial Apoptosis in db/db Mouse Infarcted HeartsPLOS ONE, 2012
- Mesenchymal Stem CellsCirculation Research, 2011
- How do angiopoietins Tie with vascular endothelial growth factors?Current Opinion in Hematology, 2010
- Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantationJournal of Molecular and Cellular Cardiology, 2008
- Angiopoietin-1 protects mesenchymal stem cells against serum deprivation and hypoxia-induced apoptosis through the PI3KAkt pathway1Acta Pharmacologica Sinica, 2008
- Intracoronary Bone Marrow Cell Transfer After Myocardial InfarctionCirculation, 2006
- Hypoxia and Serum Deprivation-Induced Apoptosis in Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2005
- Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 VectorJournal of the American College of Cardiology, 2005
- Angiopoietin‐1‐induced phosphatidyl‐inositol 3‐kinase activation prevents neuronal apoptosisThe FASEB Journal, 2003
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993